
U.S. pharmaceutical giant Eli Lilly named a new chief financial officer on Monday during a critical time for the company's exploding weight-loss drug market.
Eli Lilly promoted Lucas Montarce, who joined the company in 2001. He assumes the role abandoned by former CFO Anat Ashkenazi, who stepped down months ago to join Alphabet.